Highest development stage: Phase 4

Development active

Gram-positive activity

Gram-negative activity

Mechanism of Action/Target pathogen: For the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of Escherichia coli and Enterococcus faecalis.